Nautilus, Inc. v. Biosig Instruments, Inc.
The Court set a new standard for how clear patent claims must be: a patent is invalid for vagueness if its claims, read alongside the rest of the patent, fail to tell a skilled person in the field with reasonable certainty what the invention actually covers.
The ruling replaces a looser Federal Circuit test that only struck down claims that were 'insolubly ambiguous,' tightening the bar patent holders must meet to keep exclusive rights over their inventions.
“The definiteness requirement, so understood, mandates clarity, while recognizing that absolute precision is unattainable.”
The Court's newly announced standard for how clear patent claims must be.
How it got here: A trial court found the patent's key claim term indefinite; the Federal Circuit reversed under its own test; the losing company sought Supreme Court review.
The Case in Depth
What happened
Biosig Instruments held a patent on a heart-rate monitor built into exercise equipment, designed to filter out interference from muscle signals so it could accurately read heartbeats. Biosig sued Nautilus, a maker of exercise machines, claiming Nautilus sold equipment that used Biosig's patented technology without a license. The dispute centered on whether a key phrase in the patent's claims was clear enough to be valid.
The question before the Court
How clear does a patent's language have to be before it counts as too vague, or "indefinite," to be valid?
Why it matters
Companies that hold or challenge patents now face a stricter clarity requirement, making it easier to invalidate vaguely written patent claims. This matters for competitors deciding whether to enter a market, since clearer patent boundaries reduce the risk that ordinary business activity will be branded as accidental infringement.
What changes now
The case goes back to the Federal Circuit, which must reconsider whether the disputed patent term is definite under the Supreme Court's new reasonable-certainty standard rather than the old 'insolubly ambiguous' test. This is a final ruling on the legal standard, but the ultimate question of whether this specific patent is valid remains undecided and will be resolved on remand.
What this does not decide
The Court expressly took no position on whether the heart-rate monitor patent at issue is actually valid or invalid under the new standard, leaving that fact-specific determination for the Federal Circuit to decide on remand.
How the Court got there
The legal reasoning, step by step
- The Court identified the legal question as how much imprecision the Patent Act's definiteness requirement tolerates, since patents must describe an invention's boundaries clearly enough for others to know what is off-limits.
- The Court weighed two competing concerns: language always has some inherent imprecision, so patents aimed at people skilled in a technical field can't demand perfect clarity, but patents must still give clear enough notice so competitors know what activity risks an infringement lawsuit.
- Balancing those concerns, the Court adopted a new rule: a patent's claims are invalid for indefiniteness if they fail to inform a skilled person, with reasonable certainty, about the scope of the invention, when read alongside the patent's written description and its history before the patent office.
- The Court then evaluated the Federal Circuit's existing test, which asked only whether a claim was 'amenable to construction' or 'insolubly ambiguous,' and found that this phrasing was too loose to enforce the statute's clarity demand, because it could let claims survive even when they left real uncertainty about what was covered.
- Applying its new reasonable-certainty standard, the Court concluded that the Federal Circuit's looser test needed to be replaced, but declined to decide for itself whether this particular patent's disputed term was definite, since the Court prefers to review lower-court rulings rather than decide such fact-bound questions first.